Patent · US Active

High fidelity restriction endonucleases

US11001818B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Inventors

Key dates

Filing dateMar 15, 2019
Grant dateMay 11, 2021
Priority date
Expiry dateMar 15, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/922
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods and compositions are provided for engineering mutant enzymes with reduced star activity where the mutant enzymes have a fidelity index (FI) in a specified buffer that is greater than the FI of the non-mutated enzyme in the same buffer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.